Cargando…

Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study

BACKGROUND: Blood–brain barrier dysfunction in active multiple sclerosis (MS) lesions leads to pathological changes of cerebrospinal fluid (CSF). Theoretically, CSF analyses could help to predict relapse recovery and the course of disability. In this monocentric study, we investigated the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diem, Lara, Bürge, Maxine, Leichtle, Alexander, Hakim, Arsany, Chan, Andrew, Salmen, Anke, Evangelopoulos, Maria-Eleptheria, Hoepner, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780321/ https://www.ncbi.nlm.nih.gov/pubmed/33447262 http://dx.doi.org/10.1177/1756286420975909

Ejemplares similares

Cerebrospinal fluid analysis in Guillain–Barré syndrome: value of albumin quotients
por: Rath, Jakob, et al.
Publicado: (2021)

Sex difference in cerebrospinal fluid/blood albumin quotients in patients with schizophreniform and affective psychosis
por: Meixensberger, Sophie, et al.
Publicado: (2020)

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)

Increased age and male sex are independently associated with higher frequency of blood–cerebrospinal fluid barrier dysfunction using the albumin quotient
por: Castellazzi, Massimiliano, et al.
Publicado: (2020)

Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
por: Pistor, Maximilian, et al.
Publicado: (2022)

Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
por: Diem, Lara, et al.
Publicado: (2020)

Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study
por: Chaloulos-Iakovidis, Panagiotis, et al.
Publicado: (2021)

Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study
por: Miclea, Andrei, et al.
Publicado: (2018)

Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy
por: Rebsamen, Michael, et al.
Publicado: (2022)

An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses
por: Gili-Kovács, Judit, et al.
Publicado: (2021)

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder—MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
por: Wagner, Franca, et al.
Publicado: (2018)

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
por: Zoehner, Greta, et al.
Publicado: (2019)

Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study
por: Miclea, Andrei, et al.
Publicado: (2019)

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
por: Briner, Myriam, et al.
Publicado: (2019)

Pneumococcal serotype determines growth and capsule size in human cerebrospinal fluid
por: Müller, Annelies, et al.
Publicado: (2020)

Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
por: Marti, Stefanie, et al.
Publicado: (2023)

Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor
por: Koper-Lenkiewicz, Olga M., et al.
Publicado: (2019)

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
por: Hammer, Helly, et al.
Publicado: (2022)

Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
por: Hoepner, Robert, et al.
Publicado: (2014)

Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
por: Stoop, Marcel P., et al.
Publicado: (2010)

Homonymous hemianopsia as the leading symptom of a tumor like demyelinating lesion: a case report
por: Evangelopoulos, Maria Eleptheria, et al.
Publicado: (2009)

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
por: Friedli, Christoph, et al.
Publicado: (2021)

IL-6 Quotient (The Ratio of Cerebrospinal Fluid IL-6 to Serum IL-6) as a Biomarker of an Unruptured Intracranial Aneurysm
por: Kamińska, Joanna, et al.
Publicado: (2021)

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
por: Herman, Stephanie, et al.
Publicado: (2019)

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
por: PAVELEK, ZBYŠEK, et al.
Publicado: (2016)

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
por: Pisani, Valerio, et al.
Publicado: (2012)

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
por: Hoepner, Robert, et al.
Publicado: (2022)

Immune Reconstitution Inflammatory Syndrome Mimicking Progressive Multifocal Leucoencephalopathy in a Multiple Sclerosis Patient Treated With Natalizumab: A Case Report and Review of the Literature
por: Evangelopoulos, Maria-Eleptheria, et al.
Publicado: (2015)

Intelligence quotient is associated with epilepsy in children with intellectual disability in India
por: Lakhan, Ram
Publicado: (2013)

Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS
por: Puthenparampil, Marco, et al.
Publicado: (2021)

Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
por: Lai, Qi-Lun, et al.
Publicado: (2022)

Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis
por: Assialioui, Abdelilah, et al.
Publicado: (2022)

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data
por: Salmen, Anke, et al.
Publicado: (2023)

Treatment, Outcome, and Relapse of Spontaneous and Nonspontaneous Cerebrospinal Fluid Leak
por: Tai, Yi-Cheng, et al.
Publicado: (2022)

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System
por: Pistor, Maximilian, et al.
Publicado: (2022)

Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse
por: Longhini, Ana Leda F, et al.
Publicado: (2011)

Cerebrospinal fluid in multiple sclerosis
por: Rammohan, Kottil W.
Publicado: (2009)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients
por: Costa, Montserrat, et al.
Publicado: (2018)

Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV
por: Kakarla, Visesha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6bthqnvi2fkcd6deentecs4fr9